For this, we first assessed the chromatin accessibility levels of the highly conserved gained CRC-enhancers that are bound by YAP/TAZ (n = 195; Fig. 4g and Supplementary Data 8) in 23 diverse cancer types using ATAC-seq data obtained from TCGA17 (Fig. 5a). The gene discussed is WWTR1; the disease is cancer.